💊Establish mass production technology of Toyobo and HMT, enzymes for depression related biomarkers
Toyobo and Human Metabolome Technologies have established mass-production technologies for enzymes used for measuring depression-related biomarkers through collaborative research.
In future, Toyobo will provide this enzyme for HMT, HMT will manufacture and sell research reagent kit to measure this biomarker.
The number of patients with depression is said to be 322 million people worldwide, and domestic economic losses will be about 3 trillion yen * 2 annually.
Diagnosis of depression is currently focused mainly on medical consultation by specialists, but diagnosis with high accuracy is not easy because the onset background and symptoms vary widely.
On the other hand, research by HMT et al. Revealed that the concentration of ethanolamine phosphate (PEA) in blood fluctuates according to the medical condition of depression, suggesting its utility as a biomarker to support depression diagnosis It is.
News Releases | TOYOBO